Notice 12 Sep 2025 louisiana, compliance, advisory committee, public meeting, civil rights

🗣️Louisiana Advisory Committee Meeting Announcement - Civil Rights

Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission) and the Federal Advisory Committee Act, that the Louisiana Advisory Committee (Committee) to the U.S. Commission on Civil Rights will hold a series of public meetings via Zoom on Monday, October 27, 2025 from 10:00 a.m.-12:00 p.m. Central Time; Thursday, November 20, 2025 from 10:00 a.m.-11:00 a.m. Central Time; Wednesday, January 7, 2026 from 10:00 a.m.-11:00 a.m. Central Time and Monday, February 2, 2026 from 10:00 a.m.-11:00 a.m. Central Time. The purpose of the meeting on October 27, 2025 is for Committee members to hear testimony regarding their topic on the role of coroners in involuntary mental health commitments in Louisiana. The purpose of the meeting on November 20, 2025 is a Debriefing Meeting to discuss testimony received. The purpose of the meeting on January 7, 2026 is to discuss the 1st report draft. The purpose of February 2, 2026 meeting will be the final SAC meeting to vote on their report.

Learn More
Notice 12 Sep 2025 fsa, compliance, events, business engagement, information collection, agriculture, registration

📅FSA's Information Collection Request on Event Registration

In accordance with the Paperwork Reduction Act of 1995, the Farm Service Agency (FSA) is requesting comments from all interested individuals and organizations on a revision and an extension of the information collection associated with online and in-person registration for FSA-hosted events and conferences. The information collection is needed for FSA to obtain information from the respondents who register on the internet to access and make preparation for participation in events, and when necessary, to make payment and reservations to attend any FSA-hosted conferences and events. Additionally, the demographic data collected through this information collection assists FSA in monitoring its outreach and engagement of farmers and ranchers.

Learn More
Notice 12 Sep 2025 cultural heritage, university of alabama at birmingham, compliance, native american, nagpra, repatriation, archaeology

🏺Notice of Inventory Completion for Repatriation under NAGPRA

In accordance with the Native American Graves Protection and Repatriation Act (NAGPRA), the University of Alabama at Birmingham has completed an inventory of human remains and has determined that there is a cultural affiliation between the human remains and Indian Tribes or Native Hawaiian organizations in this notice.

Learn More
Notice 12 Sep 2025 manufacturing, compliance, business regulation, drug enforcement, controlled substances

⚗️DEA Notice

Cambridge Isotope Laboratories, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More
Notice 12 Sep 2025 securities, sec, compliance, regulation, canadian issuers, information collection

📄SEC Notice on Schedule 14D-9F Reporting Obligations

The Securities and Exchange Commission (SEC) has submitted a request for extension related to Schedule 14D-9F, which mandates reporting by Canadian foreign private issuers involved in cash tender offers. This regulatory framework aims to facilitate compliance with both Canadian law and U.S. requirements, ensuring transparency for investors in related securities.

Learn More
Notice 12 Sep 2025 arizona, cultural heritage, compliance, land management, native american, repatriation, nma, archaeology

🪶Notice of Repatriation

In accordance with the Native American Graves Protection and Repatriation Act (NAGPRA), the U.S. Department of the Interior, Bureau of Land Management (BLM), Arizona State Office, has completed an inventory of human remains and associated funerary objects and has determined that there is a cultural affiliation between the human remains and associated funerary objects and Indian Tribes in this notice.

Learn More
Notice 12 Sep 2025 cultural patrimony, cultural items, forest service, national park service, compliance, native american, nagpra, ozark-st francis

🦅Notice on Cultural Items Disposition Under NAGPRA Regulations

In accordance with the Native American Graves Protection and Repatriation Act (NAGPRA), the U.S Department of Agriculture, Forest Service, Ozark-St. Francis National Forests intends to carry out the disposition of objects of cultural patrimony removed from Federal or Tribal lands to the Indian Tribe with priority for disposition in this notice.

Learn More
Notice 12 Sep 2025 transportation, compliance, infrastructure, environment, florida, development

🚧Final Agency Actions on Florida Transportation Project Announced

The FHWA, on behalf of the State Department of Transportation (FDOT), is issuing this notice to announce actions taken by FDOT and other Federal agencies that are final agency actions. These actions relate to the proposed Canoe Creek Road Project Development and Environment (PD&E) Study from Deer Run Road to US 192 (Financial Management 449217-1). The proposed improvements consist of reconstructing the existing two-lane roadway to a four-lane divided urban roadway including multimodal improvements.

Learn More
Notice 12 Sep 2025 regulatory processes, drug enforcement administration, compliance, pharmaceuticals, controlled substances

⚖️Cambridge Isotope Laboratories Applies for Controlled Substances Import

Cambridge Isotope Laboratories, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More
Notice 12 Sep 2025 fda, compliance, drug manufacturing, remote assessments, health regulations

🏭FDA Guidance on Alternative Tools for Drug Manufacturing Assessment

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Alternative Tools: Assessing Drug Manufacturing Facilities Identified in Pending Applications." This guidance provides information to applicants on how FDA intends to use alternative tools to assess drug manufacturing facilities identified in a marketing application (i.e., a new drug application (NDA), an abbreviated new drug application (ANDA), a biologics license application (BLA), or a supplement to any of these types of applications). As part of the negotiations relating to the reauthorization of the Prescription Drug User Fee Act (PDUFA) and the Biosimilar User Fee Act (BsUFA), as described in "PDUFA Reauthorization Performance Goals and Procedures Fiscal Years 2023 Through 2027" (PDUFA VII commitment letter) and "Biosimilar Biological Product Reauthorization Performance Goals and Procedures for Fiscal Years 2023 Through 2027" (BsUFA III commitment letter), FDA agreed to issue guidance on the use of alternative tools to assess manufacturing facilities named in pending applications and to incorporate best practices from the use of such tools during the Coronavirus Disease 2019 (COVID-19) pandemic. This guidance finalizes the draft guidance of the same title issued on September 22, 2023.

Learn More